StockData

Cuprina Holdings (Cayman) vs Fractyl Health

CUPR and GUTS side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CUPR and GUTS compare

Cuprina Holdings (Cayman) scores higher on the StockData Score (3 against 1 for Fractyl Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCUPRGUTS
Size and price
Market cap–$154M
Share price$1.69$0.965
Change, 1 year−71.2%−93.6%
Beta (5Y)−0.152.53
Employees10100
StockData Score
Total score3 (better)1
Valuation score00
Growth score1 (better)0
Performance score00
Health score2 (better)1
Dividend score00
Growth
Revenue growth (TTM)3.3%–
Profitability
Gross margin−1.3%–
Operating margin−9680%–
Net margin−9367%–
FCF margin−18423%–
Return on equity−1569%–
Financial health
Debt / equity0.03–
Interest coverage−328.0×–
Current ratio2.353.15 (better)
Altman Z-score–−11.64
Piotroski F-score4 (better)3
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions0.00%4.3%
Held by insiders–5.5%
Insider net buying, 12 months–$187K
Short interest, % of float–0.39%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.